… in comparison with previous reviews. The Cochrane review and the report by Rodrigo and
colleagues pooled studies comparing … a bronchodilator effect, comparing the pooled effect of …

… results, whereas most studies comparing ICS/LABA/LAMA (triple … Studies comparing the
effect and safety of other ICSs such … benefit-risk comparisons between the other licensed ICSs. …

… direct and indirect comparisons of interventions for simultaneously comparing the effects of
… a network of interventions that enables multiple comparisons via common comparators. For …

Aims To compare the airway potency, systemic activity and therapeutic index of three inhaled
corticosteroids that differ in glucocorticoid receptor binding affinity, physicochemical and …

… Only studies comparing the safety and effectiveness of LABA … effectiveness and safety
of inhaled corticosteroids and long-… or safety of inhaled corticosteroids and bronchodilators …

… in the meta-analysis studies had to meet the following criteria: (a) inclusion of patients with
asthma of any severity; (b) use of a randomized controlled design to make a comparison of …

Background: Various combinations of inhaled corticosteroid (ICS), long-acting muscarinic
antagonist (LAMA), and long-acting beta-agonist (LABA) have been used as triple therapy for …

… To minimize the baseline differences between the comparison groups, we employed an
active control design, used the same inhaler device as a matching criterion, and included …

… Inhaled corticosteroids (ICSs) have been used widely in the maintenance therapy of COPD.
However, whether inhaled therapy containing ICSs can reduce the all-cause mortality risk …

… Only randomised controlled trials comparing the change in oral corticosteroid dose
following administration of high-dose (as defined by Global Initiative for Asthma (GINA) asthma …